Abstract
Not all bubbles in the bloodstream are detrimental. During the past decade, contrast-enhanced ultrasound has evolved from a purely investigational tool to a routine diagnostic technique. This transformation has been facilitated by advances in the microbubble contrast agents and contrast-specific ultrasound imaging techniques. The ability to non-invasively image molecular events with targeted microbubbles is likely to be important for characterizing pathophysiology and for developing new therapeutic strategies in the treatment of cardiovascular and neoplastic diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 527-532 |
Number of pages | 6 |
Journal | Nature Reviews Drug Discovery |
Volume | 3 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2004 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery